Insmed, Inc. (INSM): Price and Financial Metrics
INSM Price/Volume Stats
| Current price | $24.72 | 52-week high | $32.00 |
| Prev. close | $24.92 | 52-week low | $18.08 |
| Day low | $24.67 | Volume | 588,392 |
| Day high | $25.06 | Avg. volume | 1,757,983 |
| 50-day MA | $27.10 | Dividend yield | N/A |
| 200-day MA | $25.84 | Market Cap | 3.67B |
INSM Stock Price Chart Interactive Chart >
Insmed, Inc. (INSM) Company Bio
Insmed Incorporated is a biopharmaceutical company focused on developing targeted inhaled therapies for patients suffering from rare lung diseases. The company was founded in 1999 and is based in Bridgewater, New Jersey.
Latest INSM News From Around the Web
Below are the latest news stories about INSMED INC that investors may wish to consider to help them evaluate INSM as an investment opportunity.
Insmed Inc Chief Medical Officer Martina Flammer Sells 28,310 SharesOn December 22, 2023, Martina Flammer, the Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 28,310 shares of the company's stock, according to a recent SEC Filing. |
Investors ignore increasing losses at Insmed (NASDAQ:INSM) as stock jumps 9.0% this past weekIf you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience... |
12 Most Promising Stocks to Buy According to Hedge FundsIn this article, we will take a look at the 12 most promising stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Hedge Funds. Analysts and financial institutions are starting to release their 2024 market outlook reports and predictions and you […] |
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 14 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company. |
Insmed To Present at the Nasdaq 49th Investor ConferenceInsmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023, at 8:30 a.m. ET/1:30 p.m. GMT. |
INSM Price Returns
| 1-mo | -9.52% |
| 3-mo | -10.79% |
| 6-mo | 3.52% |
| 1-year | 28.42% |
| 3-year | -31.31% |
| 5-year | -20.18% |
| YTD | -20.23% |
| 2023 | 55.11% |
| 2022 | -26.65% |
| 2021 | -18.17% |
| 2020 | 39.41% |
| 2019 | 82.01% |
Continue Researching INSM
Want to do more research on INSMED Inc's stock and its price? Try the links below:INSMED Inc (INSM) Stock Price | Nasdaq
INSMED Inc (INSM) Stock Quote, History and News - Yahoo Finance
INSMED Inc (INSM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...